NCT06870058 - A Study of NH280105 in Healthy Adult Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 12, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions

Alzheimer Disease

Interventions

DRUG

NH280105- SAD

Dose formulation: Capsule Route of administration: oral

DRUG

NH280105- MAD

Dose formulation: Capsule Route of administration: oral

DRUG

Placebo

Matching placebo comparator

Trial Locations (1)

RECRUITING

CMAX Clinical Research Pty Ltd, Adelaide